Method for stabilizing a kit for measuring steroid hormones in a sample by competitive method
By using bovine serum albumin in the kit's aqueous medium, the stability of steroid hormone measurement kits is enhanced, allowing for accurate and stable measurement of steroid hormones over extended periods.
Patent Information
- Application Number
- JP2021053295
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-03-30
- Filing Date
- 2021-03-26
- Publication Date
- 2024-11-07
- Estimated Expiration
- 2041-03-26
AI Technical Summary
Existing measurement kits for steroid hormones using competitive methods face challenges in maintaining stability during long-term storage, particularly due to the inverse correlation between the amounts of immune complexes formed, which affects accurate measurement of the target component.
Incorporating bovine serum albumin at concentrations of 10 g/L or more, along with a pH of 7 to 8 in the aqueous medium of the second reagent, stabilizes the labeled steroid hormone in the kit, ensuring the maintenance of measurement signal integrity during long-term storage.
The method maintains a signal derived from the labeling substance in the immune complex at 70% or higher after 140 days of storage, ensuring accurate and stable measurement of steroid hormones.
Smart Images

Figure 0007579190000001 
Figure 0007579190000002 
Figure 0007579190000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for stabilizing a kit for measuring steroid hormones in a sample by a competitive method, a kit for measuring steroid hormones in a sample by a competitive method, a method for stabilizing a labeled steroid hormone, and a reagent containing a labeled steroid hormone. This application claims priority based on Japanese Patent Application No. 2020-061065, filed on March 30, 2020, the contents of which are incorporated herein by reference. [Background technology]
[0002] Steroid hormones are hormones with a steroid skeleton and a molecular weight of 300 to 400, and are classified into sex hormones, glucocorticoids, mineralocorticoids, etc., based on their functions. For clinical research on steroid hormones, methods for measuring the amount of steroid hormones in living organisms have been studied, and gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), immunoassays, etc. have been developed. Although GC-MS and LC-MS have high analytical capabilities, the analytical equipment used for these analyses is expensive and requires complicated operations such as concentration and extraction. On the other hand, immunoassays are often used in clinical research because they can measure steroid hormones easily and in a short time.
[0003] Aldosterone is a mineralocorticoid with a molecular weight of approximately 360 that is secreted from the zona glomerulosa, which belongs to the outer layer of the adrenal cortex, and its secretion mainly depends on the renin-angiotensin-aldosterone system. Aldosterone is a hormone that is extremely important for maintaining electrolyte homeostasis, circulating blood volume, and blood pressure, and acts on the mineralocorticoid receptors in the distal renal tubules to promote the reabsorption of sodium and water, thereby increasing blood pressure.
[0004] Aldosterone is used for the differential diagnosis of primary aldosteronism, Bartter syndrome, Liddle syndrome, hydroxylase deficiency such as 17α-hydroxylase deficiency and 11β-hydroxylase deficiency in the adrenal gland, and selective hypoaldosteronism. In addition, the Japan Endocrine Society Guidelines and the Japan Society of Hypertension Guidelines recommend the measurement of the aldosterone to renin ratio (ARR), which is the ratio of aldosterone concentration (Plasma Aldosterone Concentration: PAC) to renin activity (Plasma Renin Activity: PRA) or renin concentration (Active Renin Concentration: ARC), as a screening method for primary aldosteronism.
[0005] Known methods for measuring aldosterone include LC-MS and immunological assays, and known immunological assays include radioimmunoassay (RIA) and enzyme immunoassay (EIA) (see Patent Documents 1 and 2). [Prior art documents] [Patent documents]
[0006] [Patent Document 1] Japanese Patent Application Publication No. 2-057976 [Patent Document 2] JP 2017-142241 A Summary of the Invention [Problem to be solved by the invention]
[0007] Known immunoassay methods include the sandwich method, the competitive method, etc. In general, the sandwich method is used when measuring macromolecules such as proteins, and the competitive method is often used when measuring low molecular weight compounds such as steroid hormones.
[0008] The sandwich method is a method for measuring the component to be measured in a sample by, for example, reacting a component to be measured in a sample with a first antibody immobilized on a solid phase and a labeled second antibody in an aqueous medium to generate an immune complex consisting of the component to be measured, the first antibody immobilized on the solid phase, and the labeled second antibody, and then measuring the label in the generated immune complex. In a measurement kit using the sandwich method, the stability of the kit during long-term storage can be improved by increasing the amount of the first antibody or the amount of the labeled second antibody.
[0009] On the other hand, in the competitive method, for example, a component to be measured in a sample, an antibody immobilized on a solid phase, and a labeled competitor are reacted in an aqueous medium to generate an immune complex 1 consisting of the component to be measured and the antibody immobilized on the solid phase, and an immune complex 2 consisting of the labeled competitor and the antibody immobilized on the solid phase, and then the label in the generated immune complex 2 is measured. At this time, the component to be measured and the competitor competitively bind to the antibody immobilized on the solid phase, so that the amounts of the immune complexes 1 and 2 generated are inversely correlated. In this way, the amount of the immune complex 1 generated, i.e., the amount of the component to be measured in the sample, can be measured from the measurement result of the label in the immune complex 2.
[0010] As with the measurement kit using the sandwich method, the measurement kit using the competitive method also needs to have improved stability during long-term storage. However, for example, when a large amount of labeled competitor is present in the immune reaction, immune complex 2 is preferentially generated, and the amount of immune complex 1 generated is very small, so that the amount of the component to be measured in the sample cannot be accurately measured. Therefore, in the measurement kit using the competitive method, it is difficult to improve the stability during long-term storage by increasing the amount of labeled competitor.
[0011] In order to solve the above-mentioned problems, the present invention aims to provide a method for stabilizing a kit for measuring steroid hormones in a sample by a competitive method; a kit for measuring steroid hormones in a sample by a competitive method which has excellent stability during long-term storage; a method for stabilizing a labeled steroid hormone; and a labeled steroid hormone-containing reagent which has excellent stability during long-term storage. [Means for solving the problem]
[0012] As a result of intensive research to solve the above problems, the present inventors have found that, in a kit for measuring steroid hormones in a sample by a competitive method, the kit comprises a first reagent containing an anti-steroid hormone antibody and a second reagent containing a labeled steroid hormone, by allowing the labeled steroid hormone and bovine serum albumin to coexist in an aqueous medium in the second reagent, the stability of the kit during long-term storage is improved, and have completed the present invention. That is, the present invention relates to the following [1] to
[28] .
[0013] [1] A method for stabilizing a kit for measuring a steroid hormone in a sample by a competitive method, the kit comprising a first reagent containing an anti-steroid hormone antibody and a second reagent containing a labeled steroid hormone, A stabilization method comprising the step of: causing the labeled steroid hormone to coexist with 10 g / L or more of bovine serum albumin in an aqueous medium in the second reagent. [2] The stabilization method according to [1], wherein the concentration of the bovine serum albumin is 20 to 30 g / L. [3] The stabilization method according to [1] or [2], wherein the aqueous medium has a pH of 7 to 8. [4] The stabilization method described in any one of [1] to [3], wherein the labeled steroid hormone is an enzyme-labeled steroid hormone. [5] The stabilization method described in [4], wherein the enzyme is at least one enzyme selected from the group consisting of alkaline phosphatase and peroxidase. [6] The stabilization method described in any one of [1] to [5], wherein the steroid hormone is a mineralocorticoid. [7] The stabilization method described in [6], wherein the mineralocorticoid is aldosterone.
[0014] [8] a first reagent containing an anti-steroid hormone antibody; a second reagent comprising an aqueous medium, a labeled steroid hormone, and bovine serum albumin at 10 g / L or more; A kit for measuring a steroid hormone in a sample by a competitive method, comprising: [9] The kit described in [8], wherein the bovine serum albumin has a concentration of 20 to 30 g / L.
[10] The kit described in [8] or [9], wherein the aqueous medium has a pH of 7 to 8.
[11] The kit described in any one of [8] to
[10] , wherein the labeled steroid hormone is a steroid hormone labeled with an enzyme.
[12] The kit according to
[11] , wherein the enzyme is at least one enzyme selected from the group consisting of alkaline phosphatase and peroxidase.
[13] The kit according to any one of [9] to
[12] , wherein the steroid hormone is a mineralocorticoid.
[14] The kit described in
[13] , wherein the mineralocorticoid is aldosterone.
[0015]
[15] A method for stabilizing a labeled steroid hormone, which comprises causing the labeled steroid hormone to coexist with 10 g / L or more of bovine serum albumin in an aqueous medium.
[16] The stabilization method according to
[15] , wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
[17] The stabilization method according to
[15] or
[16] , wherein the aqueous medium has a pH of 7 to 8.
[18] The stabilization method described in any one of
[15] to
[17] , wherein the labeled steroid hormone is an enzyme-labeled steroid hormone.
[19] The stabilization method described in
[18] , wherein the enzyme is at least one enzyme selected from the group consisting of alkaline phosphatase and peroxidase.
[20] The stabilization method described in any one of
[15] to
[19] , wherein the steroid hormone is a mineralocorticoid.
[21] The stabilization method described in
[20] , wherein the mineralocorticoid is aldosterone.
[0016]
[22] A method for measuring a steroid hormone in a sample by a competitive method, which comprises reacting a steroid hormone in the sample with an anti-steroid hormone antibody and a labeled steroid hormone to form an immune complex between the anti-steroid hormone antibody and the labeled steroid hormone, and measuring the label in the immune complex thus formed. A labeled steroid hormone-containing reagent for use in A labeled steroid hormone-containing reagent, comprising a labeled steroid hormone and bovine serum albumin at a concentration of 10 g / L or more in an aqueous medium.
[23] The reagent described in
[22] , wherein the bovine serum albumin has a concentration of 20 to 30 g / L.
[24] The reagent according to
[22] or
[23] , wherein the aqueous medium has a pH of 7 to 8.
[25] The reagent according to any one of
[22] to
[24] , wherein the labeled steroid hormone is a steroid hormone labeled with an enzyme.
[26] The reagent described in
[25] , wherein the enzyme is at least one enzyme selected from the group consisting of alkaline phosphatase and peroxidase.
[27] The reagent described in any one of
[22] to
[26] , wherein the steroid hormone is a mineralocorticoid.
[28] The reagent described in
[27] , wherein the mineralocorticoid is aldosterone. Effect of the Invention
[0017] The present invention provides a method for stabilizing a kit for measuring steroid hormones in a sample by a competitive method; a kit for measuring steroid hormones in a sample by a competitive method, which has excellent stability during long-term storage; a method for stabilizing a labeled steroid hormone; and a labeled steroid hormone-containing reagent, which has excellent stability during long-term storage. The invention also provides a method for stabilizing a kit for measuring steroid hormones in a sample by a competitive method, without decreasing the measurement signal. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0018] Hereinafter, the embodiments of the method for stabilizing a kit for measuring steroid hormones in a sample by a competitive method, the kit for measuring steroid hormones in a sample by a competitive method, the method for stabilizing a labeled steroid hormone, and the labeled steroid hormone-containing reagent of the present invention will be described. Note that the embodiments described below are examples of typical embodiments of the present disclosure, and the scope of the disclosure should not be interpreted narrowly by them. Note that the numerical range indicated using "~" indicates a range that includes the numerical values before and after "~" as the minimum and maximum values, respectively. Furthermore, when multiple substances corresponding to each component are present in the solution, the amount of each component in the solution means the total amount of the multiple substances present in the reaction or in the reagent, unless otherwise specified.
[0019] (1) Method for stabilizing a kit for measuring steroid hormones in a sample by competitive method An embodiment of the method for stabilizing a kit for measuring steroid hormones in a sample by a competitive method (hereinafter referred to as the embodiment of the method for stabilizing the measurement kit) is a method for stabilizing a kit for measuring steroid hormones in a sample by a competitive method, which comprises a first reagent containing an anti-steroid hormone antibody and a second reagent containing a labeled steroid hormone, characterized in that in the second reagent, the labeled steroid hormone and 10 g / L or more of bovine serum albumin are coexisted in an aqueous medium.
[0020] In the stabilization method of the measurement kit of the embodiment, "stable" means that even when the measurement kit of the embodiment is stored for a long period of time and then used in the measurement method described below, the signal derived from the labeling substance in the immune complex 2 generated in step [2] of the measurement method described below is less likely to decrease compared to before storage. For example, in the stabilization method of the measurement kit of the embodiment, even when the measurement kit for measuring steroid hormones in a sample by the competitive method is stored at 5°C for 140 days and then used in the measurement method described below, the signal derived from the labeling substance in the immune complex 2 is 70% or more compared to before storage. The signal derived from the labeling substance in the immune complex 2 can be measured, for example, by the following method.
[0021] [1] A step of reacting a sample not containing a steroid hormone with a first reagent containing an anti-steroid hormone antibody and a second reagent containing a labeled steroid hormone to generate an immune complex 2 consisting of the labeled steroid hormone and the anti-steroid hormone antibody; and [2] A step of measuring the labeled substance in the immune complex 2 produced in step [1].
[0022] Before and after long-term storage of the measuring kit of the embodiment, the signal (e.g., luminescence amount) derived from the labeling substance is measured, and the ratio of the signal after storage to the signal before storage is calculated. Here, for example, if the ratio is higher than 70%, the measuring kit of the embodiment can be evaluated as being stable.
[0023] The specimen in the stabilization method of the measurement kit of the embodiment is not particularly limited as long as it is a specimen that can be measured using the measurement kit of the embodiment, and examples thereof include whole blood, plasma, serum, urine, cerebrospinal fluid, saliva, amniotic fluid, sweat, pancreatic juice, etc., with whole blood, plasma, serum, urine, etc. being preferred.
[0024] The steroid hormone in the stabilization method of the measurement kit of the embodiment is not particularly limited as long as it is a steroid hormone that enables the stabilization method of the measurement kit of the embodiment, and examples thereof include mineralocorticoids, glucocorticoids, sex hormones, etc., and mineralocorticoids are preferred. Examples of mineralocorticoids include aldosterone, fludrocortisone acetate, etc. Examples of glucocorticoids include cortisol, corticosterone, cortisone, etc. Examples of sex hormones include male hormones (androgens), female hormones, etc. Examples of male hormones include testosterone, dehydroepiandrosterone, etc. Examples of female hormones include estradiol, estriol, estrone, progesterone, etc.
[0025] In the method for stabilizing a measurement kit according to the embodiment, the kit for measuring a steroid hormone in a sample by a competitive method (hereinafter referred to as the measurement kit according to the embodiment) comprises a first reagent containing an anti-steroid hormone antibody and a second reagent containing a labeled steroid hormone. The kit may also comprise a third reagent or other reagents, for example, containing an insoluble carrier as described below.
[0026] The anti-steroid hormone antibody contained in the first reagent is not particularly limited as long as it is an antibody that binds to a steroid hormone and enables the stabilization method of the measurement kit of the embodiment, and either a polyclonal antibody or a monoclonal antibody can be used. Furthermore, in the embodiment, not only a full-length antibody but also an antibody fragment can be used. Examples of the antibody fragment include antibody fragments from which the Fc portion has been removed, such as Fab obtained by treating an antibody with papain, F(ab')2 obtained by treating with pepsin, and Fab' obtained by treating with pepsin and then reducing.
[0027] The anti-steroid hormone antibody can be produced by a conventional antibody production method using a steroid hormone itself or a compound having a partial structure corresponding to an epitope in a steroid hormone as an antigen, but it is also available as a commercially available product, such as a polyclonal antibody against any steroid hormone (manufactured by Abcam). The concentration of the anti-steroid hormone antibody is not particularly limited as long as it is a concentration that enables the stabilization method of the measurement kit of the embodiment, and is usually 0.1 to 1000 ng / mL, preferably 1 to 100 ng / mL.
[0028] The anti-steroid hormone antibody may or may not be immobilized on an insoluble carrier, but is preferably immobilized. When the anti-steroid hormone antibody is immobilized on an insoluble carrier, the insoluble carrier on which the anti-steroid hormone antibody is immobilized may be produced in the reaction solution of the antigen-antibody reaction. In this case, the anti-steroid hormone antibody bound to one of a pair of affinity substances (A) and the insoluble carrier bound to the other of the pair of affinity substances (a) are reacted in the reaction solution of the antigen-antibody reaction to produce the insoluble carrier on which the anti-steroid hormone antibody is immobilized in the reaction solution of the antigen-antibody reaction. Examples of the combination of Aa include the following combinations. Combinations of biotin and avidins (avidin, neutravidin, streptavidin, etc.); Combinations of avidins (avidin, neutravidin, streptavidin, etc.) with biotin; A combination of the Fc region of an anti-steroid hormone antibody and an antibody that binds to the Fc region.
[0029] The insoluble carrier in the embodiment is not particularly limited as long as it is an insoluble carrier capable of immobilizing an anti-steroid hormone antibody and a competing substance and enabling the stabilization method of the measurement kit of the embodiment, and examples thereof include polystyrene plates such as microtiter plates, glass or synthetic resin granules (beads), glass or synthetic resin spheres (balls), latex, magnetic particles, various membranes such as nitrocellulose membranes, synthetic resin test tubes, etc. Furthermore, when an insoluble carrier having an anti-steroid hormone antibody immobilized thereon is produced in the reaction solution of the antigen-antibody reaction, the insoluble carrier is contained in the first reagent, the second reagent or another reagent.
[0030] The first reagent may contain, as necessary, an aqueous medium, a preservative, a salt, a sugar, a surfactant, a protein, an agent for eliminating interferences, and the like. The aqueous medium is not particularly limited as long as it is an aqueous medium that enables the stabilization method of the measurement kit of the embodiment, and examples thereof include deionized water, distilled water, buffer solution, etc., and buffer solution is preferred. The pH of the buffer solution is not particularly limited as long as it enables the stabilization method of the measurement kit of the embodiment, and may be, for example, pH 4 or more, pH 5 or more, pH 6 or more, or pH 7 or more, and may be pH 8 or less or pH 9 or less, and pH 6 to 8 is preferred, and pH 7 to 8 is more preferred. In addition, in the present disclosure, a numerical range obtained by combining any numerical value selected from the upper limit example and the lower limit example for a certain amount is also considered to be exemplified in the present disclosure. The same applies to other numerical values such as concentration, period, temperature, etc.
[0031] Examples of buffering agents that can be used to prepare the buffer solution include 2-morpholinoethanesulfonic acid (MES), 3-morpholinopropanesulfonic acid (MOPS), piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES), 2-[N,N-bis(2-hydroxyethyl)amino]ethanesulfonic acid (BES), N-(2-hydroxyethyl)-N'-(2-sulfoethyl)piperazine (HEPES), bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane (Bis-Tris). , N-(2-acetamido)-2-aminoethanesulfonic acid (ACES), N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES), 3-[4-(2-hydroxyethyl)-1-piperazinyl]propanesulfonic acid (EPPS), N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid (TAPS), N-cyclohexyl-2-aminoethanesulfonic acid (CHES), and N-cyclohexyl-3-aminopropanesulfonic acid (CAPS). The concentration of the buffer is not particularly limited as long as it enables the stabilization method of the measurement kit of the embodiment, and is usually 0.001 to 2.0 mol / L, preferably 0.005 to 1.0 mol / L.
[0032] Examples of preservatives include sodium azide and antibiotics. Examples of salts include sodium chloride, sodium nitrate, sodium sulfate, sodium carbonate, sodium formate, sodium acetate, potassium chloride, potassium nitrate, potassium sulfate, potassium carbonate, potassium formate, potassium acetate, ethylenediaminetetraacetic acid (EDTA), and the like. Examples of sugars include trehalose and sucrose. Examples of surfactants include nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric surfactants. Examples of proteins include bovine serum albumin. Examples of interference removers include ascorbic acid oxidase for removing the effects of ascorbic acid.
[0033] The labeling substance used in the labeled steroid hormone is not particularly limited as long as it enables the stabilization method of the measurement kit of the embodiment, and examples thereof include enzymes, fluorescent substances, luminescent substances, radioactive isotopes, biotin, digoxigenin, polypeptides containing a tag sequence, metal colloid particles, colored latex particles, etc.
[0034] Examples of the enzyme include alkaline phosphatase, peroxidase, β-D-galactosidase, and luciferase.
[0035] Examples of fluorescent substances include fluorescein isothiocyanate (FITC), rhodamine B-isothiocyanate (RITC), etc. Other fluorescent substances include, for example, quantum dot (Science, 281, 2016-2018, 1998), phycobiliproteins such as phycoerythrin, and fluorescent proteins such as GFP (Green Fluorescent Protein), RFP (Red Fluorescent Protein), YFP (Yellow Fluorescent Protein), and BFP (Blue Fluorescent Protein).
[0036] Examples of the luminescent substance include acridinium and its derivatives, ruthenium complex compounds, lophine, etc. As the ruthenium complex compound, those which electrochemically emit light together with an electron donor and are shown in Clin. Chem. 37, 9, 1534-1539, 1991 are preferred. Examples of radioisotopes include: 3 H, 14 C. 35 S, 32 P, 125 I, 131 I etc.
[0037] Examples of polypeptides containing a tag sequence include FLAG peptide (FLAG tag, Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys), polyhistidine (His tag, His-His-His-His-His-His), myc epitope peptide (myc tag, Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu), and hemagglutinin epitope peptide (HA tag, Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala).
[0038] The labeling of steroid hormones with labeling substances can be carried out by a reaction that produces a covalent bond between a functional group of the steroid hormone and a functional group of the labeling substance, with or without a linker. Examples of the functional group include a carboxyl group, an amino group, a glycidyl group, a sulfhydryl group, a hydroxyl group, an amide group, an imino group, a hydroxysuccinyl ester group, a maleimide group, an isothiocyanate group, etc.
[0039] In labeling a steroid hormone with a labeling substance, the position in the steroid hormone where the steroid hormone binds to the labeling substance can be appropriately selected depending on the structure of the steroid hormone. For example, when the steroid hormone to be measured is aldosterone and labeled aldosterone is used as the labeled steroid hormone, the labeling substance can be bound to the 3rd, 4th, 6th, 21st, or other position of aldosterone.
[0040] Examples of the binding method that does not involve a linker include a method using a carbodiimide compound such as 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (EDC). In this case, it is also possible to use an active ester such as NHS or a derivative thereof. The condensation reaction between an isothiocyanate group and an amino group is preferable because it does not require other reagents and proceeds simply by mixing under neutral to weakly alkaline conditions.
[0041] The linker may be any molecule capable of binding a functional group of a steroid hormone to a functional group of a labeling substance. In a preferred embodiment, for example, a first functional group capable of reacting with a carboxyl group of a steroid hormone and a second functional group capable of reacting with a carboxyl group of a labeling substance are used. Examples of the functional group of the linker include a molecule having a second functional group capable of reacting with the functional group of the substance in the same molecule, and it is preferable that the first functional group and the second functional group are different. Examples of the functional group of the linker include the above-mentioned functional groups.
[0042] Methods for chemically binding radioisotopes include, for example, the method described in the literature (AntibodyImmunoconj. Radiopharm., 3, 60, 1990). Examples include:
[0043] When the labeling substance is an enzyme, avidin, a fluorescent protein, a phycobiliprotein, a polypeptide containing a tag sequence, or the like, it can be produced by preparing an expression vector containing DNA encoding a fusion protein of the labeling substance and an anti-steroid hormone antibody according to known recombinant gene technology (Molecular Cloning: A Laboratory Manual, 3rd Edition, Cold Spring Harbor Laboratory Press, 2001), introducing the expression vector into a suitable host, and culturing the host. The DNA encoding the fusion protein can be obtained by cloning the DNAs encoding the antibody and the labeling substance by PCR or the like, and linking the respective DNAs by a ligase reaction.
[0044] The method for measuring the label in the immune complex between the anti-steroid hormone antibody and the labeled steroid hormone can be appropriately selected depending on the label used.
[0045] When the labeling substance is a color-developing substance, that is, a substance that absorbs light of a certain wavelength, the absorbance can be measured using a spectrophotometer, a multiwell plate reader, or the like. When the labeling substance is a fluorescent substance, the fluorescence intensity can be measured using a fluorometer, a fluorescent multiwell plate reader, or the like. When the labeling substance is a luminescent substance, the luminescence intensity can be measured using a luminescence photometer, a luminescence multiwell plate reader, or the like. When the labeling substance is a radioisotope, the radioactivity can be measured using a scintillation counter, a γ-well counter, or the like.
[0046] When the labeling substance is an enzyme, the amount of label can be quantified by measuring the enzyme activity, for example, by reacting the enzyme with a substrate of the enzyme and measuring the amount of the product.
[0047] When the enzyme is alkaline phosphatase, alkaline phosphatase activity can be measured, for example, by a luminescence method, etc. Examples of methods for measuring alkaline phosphatase activity by a luminescence method include a method in which alkaline phosphatase is reacted with its substrate and the luminescence intensity of the generated luminescence is measured using a luminescence photometer, a luminescence multiwell plate reader, or the like.
[0048] Substrates for alkaline phosphatase include, for example, 3-(2'-spiroadamantane)-4-methoxy-4-(3'-phosphoryloxy)phenyl-1,2-dioxetane disodium salt (AMPPD), 2-chloro-5-{4-methoxyspiro[1,2-dioxetane-3,2'-(5'-chloro)tricyclo[3.3.1.1 3.7 ]Decan]-4-yl}phenyl phosphate, disodium salt (CDP-Star TM ), 3-{4- Methoxyspiro[1,2-dioxetane-3,2'-(5'-chloro)tricyclo[3.3.1.1 3.7 ]Decan]-4-yl}phenyl phosphate disodium salt (CSPD TM ), [10-methyl-9(10H)-acridinylidene]phenoxymethylphosphoric acid Acid, disodium salt (LumigenTM APS-5) etc.
[0049] When the enzyme is peroxidase, the peroxidase activity can be measured by, for example, an absorbance method, a fluorescence method, etc. Examples of methods for measuring peroxidase activity by absorbance include a method in which peroxidase is reacted with a combination of its substrates, hydrogen peroxide, and an oxidative color-developing chromogen, and the absorbance of the reaction solution is measured using a spectrophotometer, a multiwell plate reader, etc. Examples of oxidative color-developing chromogens include leuco chromogens and oxidative coupling color-developing chromogens.
[0050] Leuco chromogens are substances that are converted to dyes by themselves in the presence of peroxidatively active substances such as hydrogen peroxide and peroxidase. Specifically, tetramethylbenzidine, o-phenylenediamine, 10-N-carboxymethylcarbamoyl-3,7-bis(dimethylamino)-10H-phenothiazine (CCAP), 10-N-methylcarbamoyl-3,7-bis(dimethylamino)-10H-phenothiazine (MCDP), N-(carboxymethylaminocarbonyl)-4,4'-bis(dimethylamino)diphenylamine sodium salt (DA-64), 10-N-carboxymethylcarbamoyl-3,7-bis(dimethylamino)-10H-phenothiazine sodium salt (DA-67), 4,4'-bis(diphenylamine) methylamino)diphenylamine, bis[3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl]amine (BCMA), and the like.
[0051] Oxidative coupling color-developing chromogens are substances that generate dyes by oxidative coupling of two compounds in the presence of hydrogen peroxide and peroxidase or other peroxidatively active substances. Examples of combinations of two compounds include a combination of a coupler and an aniline (Trinder's reagent) and a combination of a coupler and a phenol.
[0052] Examples of the coupler include 4-aminoantipyrine (4-AA) and 3-methyl-2-benzothiazolinone hydrazine.
[0053] Anilines include N-(3-sulfopropyl)aniline, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline (TOOS), N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethylaniline (MAOS), N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline (DAOS), N-ethyl-N-(3-sulfopropyl)-3-methylaniline (TOPS), N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline (HDAOS), N,N-dimethyl-3-methylaniline, N,N-bis(3-sulfopropyl)-3,5-dimethoxyaniline, N-ethyl-N-(3-sulfopropyl)-3-methoxyaniline, N- Ethyl-N-(3-sulfopropyl)aniline, N-ethyl-N-(3-sulfopropyl)-3,5-dimethoxyaniline, N-(3-sulfopropyl)-3,5-dimethoxyaniline, N-ethyl-N-(3-sulfopropyl)-3,5-dimethylaniline, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methoxyaniline, N-ethyl-N-(2-hydroxy-3-sulfopropyl)aniline, N-ethyl-N-(3-methylphenyl)-N'-succinylethylenediamine (EMSE), N-ethyl-N-(3-methylphenyl)-N'-acetylethylenediamine, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-4-fluoro-3,5-dimethoxyaniline (F-DAOS), and the like.
[0054] Examples of phenols include phenol, 4-chlorophenol, 3-methylphenol, and 3-hydroxy-2,4,6-triiodobenzoic acid (HTIB).
[0055] An example of a method for measuring peroxidase activity by a fluorescence method is a method in which peroxidase is reacted with a combination of its substrate, hydrogen peroxide, and a fluorescent substance, and the intensity of the generated fluorescence is measured using a fluorometer, a fluorescent multiwell plate reader, etc. Examples of the fluorescent substance include 4-hydroxyphenylacetic acid, 3-(4-hydroxyphenyl)propionic acid, and coumarin.
[0056] An example of a method for measuring peroxidase activity using a luminescence method is a method in which peroxidase is reacted with a combination of its substrate, hydrogen peroxide, and a luminescent substance, and the intensity of the luminescence generated is measured using a luminescence spectrometer, a luminescence multiwell plate reader, etc. Examples of the luminescent substance include luminol compounds, lucigenin compounds, etc.
[0057] When the enzyme is β-D-galactosidase, the β-D-galactosidase activity can be measured by, for example, an absorbance method (colorimetric method), a luminescence method, or a fluorescence method. An example of a method for measuring the β-D-galactosidase activity by the absorbance method (colorimetric method) is a method in which β-D-galactosidase is reacted with its substrate and the absorbance of the reaction solution is measured using a spectrophotometer, a multiwell plate reader, or the like. An example of a substrate for β-D-galactosidase is o-nitrophenyl-β-D-galactopyranoside. An example of a method for measuring the β-D-galactosidase activity by the luminescence method is a method in which β-D-galactosidase is reacted with its substrate and the luminescence intensity of the reaction solution is measured using a luminescence photometer, a luminescence multiwell plate reader, or the like. Examples of substrates for β-D-galactosidase include Galacton-Plus (Applied Biosystems) and compounds similar thereto. Methods for measuring β-D-galactosidase activity by the fluorescence method include reacting β-D-galactosidase with its substrate and measuring the fluorescence intensity of the reaction solution with a fluorometer or a fluorescent multiwell plate reader. Examples of substrates for β-D-galactosidase include 4-methylumbelliferyl-β-D-galactopyranoside.
[0058] When the enzyme is luciferase, the luciferase activity can be measured, for example, by a luminescence method. Examples of a method for measuring luciferase activity by a luminescence method include a method in which luciferase is reacted with its substrate and the luminescence intensity of the reaction solution is measured using a luminescence photometer or a luminescence multiwell plate reader. Examples of luciferase substrates include luciferin and coelenterazine.
[0059] When the labeling substance is other than a fluorescent substance, a luminescent substance, a radioisotope, or an enzyme, a substance that specifically binds to the labeling substance is labeled with a fluorescent substance, a luminescent substance, a radioisotope, an enzyme, or the like, and the labeling substance constituting the labeled steroid hormone in the immune complex is bound to the labeling substance, and the fluorescent substance, luminescent substance, radioisotope, or enzyme that labels the substance that specifically binds to the labeling substance is measured by the above-mentioned method, so that the labeling substance can be measured. Examples of substances that specifically bind to the labeling substance include antibodies that specifically bind to the labeling substance, and when the labeling substance is biotin, avidins and the like.
[0060] The concentration of the labeled steroid hormone contained in the second reagent is not particularly limited as long as it is a concentration that enables the stabilization method of the measurement kit of the embodiment, and may be, for example, 0.1 μg / mL or more, 0.2 μg / mL or more, 0.3 μg / mL or more, 0.4 μg / mL or more, 0.5 μg / mL or more, 0.6 μg / mL or more, 0.7 μg / mL or more, 0.8 μg / mL or more, 0.9 μg / mL or more, or 1 μg / mL or more, and may be 2 μg / mL or less, 3 μg / mL or less, 4 μg / mL or less, 5 μg / mL or less, 6 μg / mL or less, 7 μg / mL or less, 8 μg / mL or less, 9 μg / mL or less, 10 μg / mL or less, 15 μg / mL or less, 20 μg / mL or less, 25 μg / mL or less, 26 μg / mL or less, 27 μg / mL or less, 28 μg / mL or less, 29 μg / mL or less, 30 μg / mL or less, 31 μg / mL or less, 32 μg / mL or less, 33 μg / mL or less, 34 μg / mL or less, 35 μg / mL or less, 36 μg / mL or less, 37 μg / mL or less, 38 μg / mL or less, 39 μg / mL or less, 40 μg / mL or less, 41 μg / mL or less, 42 μg / mL or less, 43 μg / mL or less, 44 μg / mL or less, 45 μg / mL or less, 46 μg / mL or less, 47 μg / mL or less, 48 μg / mL or less, 49 μg / mL or less, The range may be 0.1 to 100 μg / mL or less, 25 μg / mL or less, 30 μg / mL or less, 35 μg / mL or less, 40 μg / mL or less, 45 μg / mL or less, 50 μg / mL or less, 60 μg / mL or more, 70 μg / mL or less, 80 μg / mL or less, 90 μg / mL or less, 100 μg / mL or less, 150 μg / mL or less, 200 μg / mL or less, 250 μg / mL or less, 300 μg / mL or less, 350 μg / mL or less, 400 μg / mL or less, 450 μg / mL or less, 500 μg / mL or less, 600 μg / mL or less, 700 μg / mL or less, 800 μg / mL or less, 900 μg / mL or less, or 1 mg / mL or less, with 0.1 to 100 μg / mL being preferred.
[0061] The concentration of bovine serum albumin contained in the second reagent is not particularly limited as long as it is a concentration that enables the stabilization method of the measurement kit of the embodiment, and may be, for example, 10 g / L or more, 15 g / L or more, 20 g / L or more, 25 g / L or more, 30 g / L or more, 35 g / L or more, 40 g / L or more, 45 g / L or more, or 50 g / L or more. In addition, the concentration of bovine serum albumin is desirably set so as not to cause too high viscosity, taking into consideration the possibility of affecting the amount of sampling of the second reagent by a reagent dispensing member of the measuring device when the measuring device is used. In this case, the concentration of bovine serum albumin may be, for example, 30 g / L or less, 35 g / L or less, 40 g / L or less, 45 g / L or less, 50 g / L or less, 55 g / L or less, 60 g / L or less, 65 g / L or less, 70 g / L or less, 75 g / L or less, or 80 g / L or less. The above numerical ranges can be freely combined. For example, the concentration of bovine serum albumin in the second reagent may be 10 to 30 g / L, or 20 to 30 g / L.
[0062] The aqueous medium contained in the second reagent is not particularly limited as long as it is an aqueous medium that enables the stabilization method of the measurement kit of the embodiment, and examples thereof include the above-mentioned deionized water, distilled water, buffer solution, etc., and buffer solution is preferred. The pH of the buffer solution is not particularly limited as long as it enables the stabilization method of the measurement kit of the embodiment and the measurement using the measurement kit of the embodiment, and may be, for example, pH 4 or more, pH 5 or more, pH 6 or more, or pH 7 or more, and may be pH 8 or less or pH 9 or less, and pH 6 to 8 is preferred, and pH 7 to 8 is more preferred. The buffering agent and its concentration used to prepare the buffer solution are not particularly limited as long as they are an aqueous medium that enables the stabilization method of the measurement kit of the embodiment, and examples thereof include the buffering agents and their concentrations described above.
[0063] The second reagent may contain the above-mentioned preservatives, salts, sugars, surfactants, proteins, interfering substance removers, and the like, as necessary.
[0064] In the stabilization method of the measurement kit of the embodiment, the storage period of the measurement kit of the embodiment is not particularly limited as long as it is a storage period that enables the stabilization method of the measurement kit of the embodiment, and may be, for example, 1 day or more, 2 days or more, 3 days or more, 4 days or more, 5 days or more, 6 days or more, 1 week or more, 2 weeks or more, 3 weeks or more, 4 weeks or more, 1 month or more, 2 months or more, 3 months or more, 4 months or more, 5 months or more, 6 months or more, 7 months or more, 8 months or more, 9 months or more, 10 months or more, 11 months or more, or 1 year or more, and may be 1.5 years or less, 2 years or less, 2.5 years or less, or 3 years or less, with 4 weeks to 1.5 years being preferred. In the embodiment of the stabilization method of the measurement kit, the storage temperature of the measurement kit is not particularly limited as long as it is a storage temperature that enables the stabilization method of the measurement kit of the embodiment, and may be, for example, 5°C or higher, 10°C or lower, 15°C or lower, 20°C or lower, 25°C or lower, 30°C or lower, 35°C or lower, 40°C or lower, 45°C or lower, or 50°C or lower, with 5°C to 30°C being preferred.
[0065] The measurement kit of the embodiment can be used in a method for measuring a steroid hormone in a sample, the method comprising the following steps.
[0066] [1] a step of reacting a specimen with a first reagent containing an anti-steroid hormone antibody in an aqueous medium to produce an immune complex 1 consisting of a steroid hormone in the specimen and the anti-steroid hormone antibody; [2] a step of adding a second reagent containing a labeled steroid hormone to the reaction solution of the step [1] and reacting to generate an immune complex 2 consisting of the labeled steroid hormone and an anti-steroid hormone antibody; [3] A step of measuring the labeled substance in the immune complex 2 produced in the step [2].
[0067] By further including the following steps after the step [3], the concentration of a steroid hormone in a sample can be determined. [4] carrying out the steps [1] to [3] above using a steroid hormone of known concentration instead of a sample, and creating a calibration curve showing the relationship between the steroid hormone concentration and the measured value of the labeled substance; and [5] A step of determining the concentration of the steroid hormone in the sample from the calibration curve prepared in the step [4] and the measured value of the labeled substance measured in the step [3].
[0068] The specimen, steroid hormone, aqueous medium, anti-steroid hormone antibody, labeled steroid hormone, and labeled substance in the measurement method are not particularly limited as long as they enable measurement using the measurement kit of the embodiment, and examples thereof include the specimen, steroid hormone, aqueous medium, anti-steroid hormone antibody, labeled steroid hormone, and labeled substance.
[0069] The concentrations of the aqueous medium, anti-steroid hormone antibody, labeled steroid hormone and labeled substance in the reaction solution in the measurement method are not particularly limited as long as they are concentrations that enable measurement using the measurement kit of the embodiment, and can be set appropriately depending on the concentrations in the first reagent and the second reagent, as well as the mixing ratio of the sample to the first reagent and the second reagent.
[0070] The reaction temperature in the steps [1] and [2] in the measurement method is not particularly limited as long as it is a temperature that allows measurement using the measurement kit of the embodiment, and is usually 0 to 50° C., preferably 4 to 45° C., and particularly preferably 20 to 40° C. The reaction time of the reaction is not particularly limited as long as it is a temperature that allows measurement using the measurement kit of the embodiment, and is usually 1 minute to 2 hours, and preferably 2 minutes to 1 hour.
[0071] When the measurement kit of the embodiment containing bovine serum albumin is used as it is in the measurement method, bovine serum albumin is present in the antibody [1] and / or step [2]. In this case, the bovine serum albumin is not particularly limited as long as it is a bovine serum albumin that can be measured using the measurement kit of the embodiment, and examples thereof include the above-mentioned bovine serum albumin.
[0072] (2) A kit for measuring steroid hormones in samples using the competitive method The kit for measuring steroid hormones in a sample by a competitive method (measurement kit of the embodiment) of the present invention is a kit for measuring steroid hormones in a sample by a competitive method comprising a first reagent containing an anti-steroid hormone antibody; and a second reagent containing an aqueous medium, a labeled steroid hormone, and 10 g / L or more of bovine serum albumin, and is, for example, a kit used in the method for measuring steroid hormones in a sample.
[0073] The sample, steroid hormone, first reagent, anti-steroid hormone antibody, second reagent containing bovine serum albumin, aqueous medium, and labeled steroid hormone in the measurement kit of the embodiment are not particularly limited as long as they enable measurement using the measurement kit of the embodiment, and examples thereof include the above-mentioned sample, steroid hormone, first reagent, anti-steroid hormone antibody, second reagent containing bovine serum albumin, aqueous medium, and labeled steroid hormone.
[0074] The concentrations of the anti-steroid hormone antibody, the labeled steroid hormone, the bovine serum albumin, and the buffer used to prepare the buffer solution as the aqueous medium in the measurement kit of the embodiment are not particularly limited as long as they are concentrations that enable measurement using the measurement kit of the embodiment, and examples of such concentrations include the concentrations of the anti-steroid hormone antibody, the labeled steroid hormone, the bovine serum albumin, and the buffer solution used to prepare the buffer solution as the aqueous medium in the measurement kit of the above embodiment. The pH of the buffer solution as the aqueous medium in the measurement kit of the embodiment is not particularly limited as long as it is a pH that allows measurement using the measurement kit of the embodiment, and examples thereof include the pHs mentioned above.
[0075] (3) Method for stabilizing labeled steroid hormones In one embodiment, a method for stabilizing a labeled steroid hormone is a method for stabilizing a labeled steroid hormone, characterized in that the labeled steroid hormone and 10 g / L or more of bovine serum albumin are coexisted in an aqueous medium, and the labeled steroid hormone is used in the method for measuring steroid hormones in a sample.
[0076] In the embodiment of the method for stabilizing a labeled steroid hormone, "stable" means that even when the labeled steroid hormone is stored for a long period of time and then used in the method for measuring steroid hormones in a sample, the signal derived from the labeled substance in the immune complex 2 generated in step [2] of the measurement method is less likely to decrease compared to before storage; for example, even when the labeled steroid hormone is stored at 5°C for 140 days and then used in the measurement method, the signal derived from the labeled substance in the immune complex 2 is 70% or more compared to before storage. The signal derived from the labeling substance in the immune complex 2 can be measured, for example, by the following method.
[0077] [1] A step of reacting a sample not containing a steroid hormone with an anti-steroid hormone antibody and an aqueous medium containing a labeled steroid hormone to generate an immune complex 2 consisting of the labeled steroid hormone and the anti-steroid hormone antibody; and [2] A step of measuring the labeled substance in the immune complex 2 produced in the step [1].
[0078] Before and after the labeled steroid hormone of the embodiment is stored for a long period of time, the signal derived from the labeling substance is measured, and the ratio of the signal after storage to the signal before storage is calculated. Here, for example, if the ratio is higher than 70%, the measurement kit of the embodiment can be evaluated as stable.
[0079] In the embodiment of the method for stabilizing a labeled steroid hormone, the labeled steroid hormone and its concentration are not particularly limited as long as they are capable of stabilizing a labeled steroid hormone in the embodiment of the invention, and examples thereof include the labeled steroid hormones and their concentrations described above.
[0080] In the method for stabilizing a labeled steroid hormone according to the embodiment, the labeled steroid hormone is made to coexist with bovine serum albumin in an aqueous medium. The concentration of bovine serum albumin is not particularly limited as long as it is a concentration that enables the stabilization method of the labeled steroid hormone of the embodiment, and examples thereof include the above-mentioned concentrations of bovine serum albumin.
[0081] The aqueous medium is not particularly limited as long as it is an aqueous medium that enables the method for stabilizing a labeled steroid hormone of the embodiment, and examples thereof include the above-mentioned deionized water, distilled water, buffer solution, etc., and buffer solution is preferred. The pH of the buffer solution is not particularly limited as long as it enables the method for stabilizing a labeled steroid hormone of the embodiment and the method for measuring a steroid hormone in a sample, and may be, for example, pH 4 or more, pH 5 or more, pH 6 or more, or pH 7 or more, or may be pH 8 or less or pH 9 or less, and pH 6 to 8 is preferred, and pH 7 to 8 is more preferred. The buffering agent and its concentration used to prepare the buffer solution are not particularly limited as long as they are an aqueous medium that enables the stabilization method of the labeled steroid hormone of the embodiment, and examples thereof include the buffering agents and their concentrations described above.
[0082] The aqueous medium may contain, as necessary, the above-mentioned anti-steroid hormone antibody, insoluble carrier, preservative, salt, sugar, surfactant, protein, interfering substance remover, and the like.
[0083] In the embodiment of the method for stabilizing a labeled steroid hormone, the storage period of the labeled steroid hormone is not particularly limited as long as it is a storage period that enables the embodiment of the method for stabilizing a labeled steroid hormone, and may be, for example, 1 day or more, 2 days or more, 3 days or more, 4 days or more, 5 days or more, 6 days or more, 1 week or more, 2 weeks or more, 3 weeks or more, 4 weeks or more, 1 month or more, 2 months or more, 3 months or more, 4 months or more, 5 months or more, 6 months or more, 7 months or more, 8 months or more, 9 months or more, 10 months or more, 11 months or more, or 1 year or more, and may be 1.5 years or less, 2 years or less, 2.5 years or less, or 3 years or less, with 4 weeks to 1.5 years being preferred. In the embodiment of the method for stabilizing a labeled steroid hormone, the storage temperature of the labeled steroid hormone is not particularly limited as long as it is a storage temperature that enables the embodiment of the method for stabilizing a labeled steroid hormone, and may be, for example, 5°C or higher, and 10°C or lower, 15°C or lower, 20°C or lower, 25°C or lower, 30°C or lower, 35°C or lower, 40°C or lower, 45°C or lower, or 50°C or lower, with 5°C to 30°C being preferred.
[0084] (4) Labeled steroid hormone-containing reagents In one embodiment, the labeled steroid hormone-containing reagent is a labeled steroid hormone-containing reagent used in a method for measuring steroid hormones in a sample by a competitive method, in which a steroid hormone in the sample is reacted with an anti-steroid hormone antibody and a labeled steroid hormone to form an immune complex between the anti-steroid hormone antibody and the labeled steroid hormone, and the label in the immune complex formed is measured.The labeled steroid hormone-containing reagent is characterized in that the labeled steroid hormone is coexisted with 10 g / L or more of bovine serum albumin in an aqueous medium.
[0085] The specimen, steroid hormone, anti-steroid hormone antibody, labeled steroid hormone, and aqueous medium in the labeled steroid hormone-containing reagent of the embodiment are not particularly limited as long as they enable the measurement of the steroid hormone in the specimen, and examples thereof include the specimen, steroid hormone, anti-steroid hormone antibody, labeled steroid hormone, and aqueous medium.
[0086] The concentrations of the anti-steroid hormone antibody, the labeled steroid hormone, the bovine serum albumin, and the buffer used to prepare the buffer solution as the aqueous medium in the labeled steroid hormone-containing reagent of the embodiment are not particularly limited as long as they enable the above-mentioned method for measuring steroid hormones in a sample, and examples of such concentrations include the concentrations of the anti-steroid hormone antibody, the labeled steroid hormone, the bovine serum albumin, and the buffer used to prepare the buffer solution as the aqueous medium in the labeled steroid hormone-containing reagent. The pH of the buffer solution as the aqueous medium in the labeled steroid hormone-containing reagent of the embodiment is not particularly limited as long as it enables the above-mentioned method for measuring the steroid hormone in the sample, and examples thereof include the above-mentioned pHs.
[0087] The aqueous medium may contain, as necessary, the above-mentioned anti-steroid hormone antibody, insoluble carrier, preservative, salt, sugar, surfactant, protein, interfering substance remover, and the like. EXAMPLES
[0088] The present invention will now be described in more detail with reference to examples, but the present invention is not limited to the following examples.
[0089] Information on the reagents and equipment used is shown below. "Biotinylated antibody" solution, "SA-bound particle" solution, "Standard aldosterone reagent A", "Standard aldosterone reagent B", "Standard aldosterone reagent C" and "Standard aldosterone reagent D" from Determiner CL Aldosterone (a kit for measuring aldosterone in samples by competitive method; Hitachi Chemical Diagnostics Systems), PIPES (Dojindo Laboratories), MOPS (Dojindo Laboratories), Tween 20 (polyoxyethylene sorbitan monolaurate; Tokyo Chemical Industry Co., Ltd.), bovine serum albumin (BOVOGEN), fully automated chemiluminescence immunoassay device CL-JACK NX (Hitachi Chemical Diagnostics Systems).
[0090] Example 1 The following aldosterone measurement kits A, B, C, D, and E were prepared, each consisting of a first reagent containing a biotin-conjugated anti-aldosterone antibody, a second reagent containing alkaline phosphatase-labeled aldosterone, and a third reagent containing streptavidin-conjugated magnetic particles.
[0091] <First reagent: biotin-conjugated anti-aldosterone antibody solution> A "biotinylated antibody" solution of Determiner CL Aldosterone was prepared as a first reagent containing a biotin-conjugated anti-aldosterone antibody in a kit for measuring aldosterone in a sample by a competitive method.
[0092] <Second reagent: alkaline phosphatase-labeled aldosterone solution> ALDOSTERONE 3-CMO (aldosterone 3-carboxymethyloxime; STERALOIDS) was mixed with Sulfo-NHS (Thermo Fisher Scientific) and EDC [1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride; Thermo Fisher Scientific] in a 3:1 mixed solvent of DMSO (Sigma-Aldrich) and water, and reacted at 25°C for 15 minutes, and then reacted with alkaline phosphatase (Roche Diagnostics) for 16 hours at 4°C. The reaction mixture was applied to a Sephadex G-50 column (GE Healthcare Japan) to remove unreacted ALDOSTERONE 3-CMO, and alkaline phosphatase-labeled aldosterone was obtained. The alkaline phosphatase-labeled aldosterone obtained was used to prepare a second reagent consisting of the following composition.
[0093] PIPES (pH see Table 1 or Table 2) 30mmol / L Alkaline phosphatase-labeled aldosterone 1.5μg / mL Tween 20 10g / L Magnesium chloride hexahydrate 30mmol / L Bovine serum albumin (concentration as shown in Table 1 or Table 2)
[0094] <Third reagent: streptavidin-bound magnetic particle suspension> A solution of "SA-bound particles" of Determiner CL Aldosterone was prepared as a third reagent containing streptavidin-bound magnetic particles in a kit for measuring aldosterone in a sample by the competitive method.
[0095] Comparative Example 1 A first reagent containing a biotin-conjugated anti-aldosterone antibody, a second reagent containing alkaline phosphatase-labeled aldosterone, and a third reagent containing streptavidin-conjugated magnetic particles were prepared in the same manner as in the second reagent of the aldosterone measurement kit A of Example 1, except that the concentration of bovine serum albumin in the second reagent was 6 g / L, and kit a consisting of the first reagent, the second reagent, and the third reagent was prepared.
[0096] Example 2 The stability of the aldosterone measurement kit A of Example 1 was evaluated by the following steps. (1) Determination of signals derived from labeled substances in the kit immediately after preparation Measurement was performed using a fully automated chemiluminescence immunoassay device CL-JACK NX. A solution (aldosterone concentration: 0 pg / mL, hereinafter referred to as standard A) (10 μL) of standard aldosterone reagent A (lyophilized product) dissolved in 0.5 mL of purified water and a first reagent (50 μL) containing biotin-bound anti-aldosterone antibody of Example 1 immediately after preparation were added to a reaction vessel, stirred, and reacted at 37 ° C for 18 minutes, and then a third reagent (30 μL) containing streptavidin-bound magnetic particles of Example 1 immediately after preparation and a second reagent (30 μL) containing alkaline phosphatase-labeled aldosterone of Kit A of Example 1 immediately after preparation were added to the reaction solution of the reaction, stirred, and reacted at 37 ° C for 8 minutes. The magnetic particles were collected by magnetic force, and the reaction solution other than the magnetic particles was removed. Then, a washing solution [50 mmol / L MOPS buffer (pH 7.35) containing 0.1% Tween 20] was added to the reaction vessel to wash the magnetic particles. The magnetic particles were collected by magnetic force, and the solution other than the magnetic particles was removed. Then, a washing solution was added to the reaction vessel to wash the magnetic particles. After this series of operations of magnetic collection, removal of the solution other than the magnetic particles, and washing the magnetic particles with the washing solution was repeated five times, a luminescent substrate solution (70 μL) mainly composed of 9-(4-chlorophenylthiophosphoryloxymethylidene)-10-methylacridan·disodium salt was added and stirred, and the amount of luminescence (RLU) generated was measured, and the amount of luminescence when measuring standard A with Kit A immediately after preparation was determined. In addition, the luminescence intensity during measurement of standards B, C, and D in kit A immediately after preparation was determined in a similar manner, except that a solution of standard aldosterone reagent B (lyophilized product) dissolved in 0.5 mL of purified water (aldosterone concentration: 50.1 pg / mL, hereafter referred to as standard B), a solution of standard aldosterone reagent C (lyophilized product) dissolved in 0.5 mL of purified water (aldosterone concentration: 196.6 pg / mL, hereafter referred to as standard C), and a solution of standard aldosterone reagent D (lyophilized product) dissolved in 0.5 mL of purified water (aldosterone concentration: 1653.9 pg / mL, hereafter referred to as standard D) were used instead of standard A.
[0097] (2) Long-term storage of the kit After the measurement in step (1), the kit A of Example 1 was stored at 5° C. for 4 weeks. (3) Determination of signals derived from labeled substances in kits after long-term storage The luminescence intensity was measured in the same manner as in step (1), except that the first, second and third reagents stored at 5°C for 4 weeks in step (2) were used instead of the first, second and third reagents immediately after preparation, and the luminescence intensity at the time of measurement of each of the standards A, B, C and D in kit A after long-term storage was determined. (4) Evaluation of kit stability The ratio of the amount of luminescence when measuring standard A in kit A after long-term storage determined in step (3) to the amount of luminescence when measuring standard A in kit A immediately after preparation determined in step (1) was taken as 100, i.e., the residual rate of the amount of luminescence when measuring standard A was calculated. In addition, the residual rate of the amount of luminescence when measuring each of standards B, C, and D was calculated by the same method. The average value of the residual rate of the amount of luminescence when measuring each of standards A, B, C, and D obtained was taken as the residual rate of the signal derived from the labeling substance in kit A, and the stability of kit A was evaluated. The results are shown in Table 1.
[0098] Example 3 The stability of Kits B to D was evaluated in the same manner as in Example 2, except that Kits B to D of Example 1 were used instead of the aldosterone measurement Kit A of Example 1. The results are shown in Table 1.
[0099] Comparative Example 2 The stability of kit a was evaluated in the same manner as in Example 2, except that kit a of Comparative Example was used instead of aldosterone measurement kit A of Example 1. The results are shown in Table 1.
[0100] [Table 1]
[0101] As is clear from Table 1, when Kit A of Comparative Example 1, in which the concentration of bovine serum albumin in the second reagent is 6 g / L, was used, the remaining rate of the signal derived from the labeled substance was higher, being 70% or more, when Kits A to D of Example 1, in which the concentration of bovine serum albumin in the second reagent is 10 g / L or more, were used. Therefore, it has become clear that a kit for measuring steroid hormones in a sample, which comprises a first reagent containing an anti-steroid hormone antibody and the second reagent containing a labeled steroid hormone, is stabilized by allowing the labeled steroid hormone and 10 g / L or more of bovine serum albumin to coexist in an aqueous medium in the second reagent. As is clear from Table 1, the kit D of Example 1, in which the second reagent containing alkaline phosphatase-labeled aldosterone has a pH of 6.5 and the concentration of bovine serum albumin in the second reagent is 6 g / L, shows a high residual rate of the signal derived from the labeling substance, 80% or more, compared with the kit a of Comparative Example 1, in which the second reagent has a pH of 7 or more and the concentration of bovine serum albumin in the second reagent is 10 g / L or more. Therefore, it was revealed that the kit for measuring steroid hormones in a sample, which contains a first reagent containing an anti-steroid hormone antibody and the second reagent containing a labeled steroid hormone, is stabilized by adjusting the pH of the second reagent to 7 or more and allowing the labeled steroid hormone and 10 g / L or more of bovine serum albumin to coexist in an aqueous medium in the second reagent.
[0102] Example 4 The stability of the aldosterone measurement kit C or E of Example 1 was evaluated in the same manner as in Example 2, except that the long-term storage in step (2) was storage at 5°C for 140 days instead of storage at 5°C for 4 weeks. The results are shown in Table 2.
[0103] Comparative Example 3 The stability of kit a was evaluated in the same manner as in Example 4, except that kit a of the comparative example was used instead of aldosterone measurement kit C or E of Example 1. The results are shown in Table 2.
[0104] [Table 2]
[0105] As is clear from Table 2, when Kit A of Comparative Example 1, in which the concentration of bovine serum albumin in the second reagent containing alkaline phosphatase-labeled aldosterone is 6 g / L, is used, the remaining rate of the signal derived from the labeling substance is high, 70% or more, when Kits C and E of Example 1, in which the concentration of bovine serum albumin in the second reagent is 20 g / L or more, are used. Therefore, it was revealed that the kit for measuring steroid hormones in a sample, which includes the first reagent containing an anti-steroid hormone antibody and the second reagent containing a labeled steroid hormone, is stabilized by allowing the labeled steroid hormone and bovine serum albumin of 20 g / L or more to coexist in an aqueous medium in the second reagent.
[0106] Example 5 The ratio of the amount of luminescence obtained in Example 4 when measuring standard A in kit C or E immediately after preparation was calculated based on the amount of luminescence obtained in Comparative Example 3 when measuring standard A in kit a immediately after preparation. Similarly, the ratio of the amount of luminescence obtained in each measurement of standard B, C, and D was also calculated. The results are shown in Table 3.
[0107] [Table 3]
[0108] In general, since steroid hormones are considered to interact with albumin, when using kits C and E of Example 1, which have a high concentration of bovine serum albumin in the second reagent, there was a concern that the bovine serum albumin bound to the labeled steroid hormone would be removed together with the reaction solution in the step of collecting the magnetic particles by magnetic force and removing the reaction solution other than the magnetic particles in the measurement, and thus the amount of luminescence (signal derived from the labeling substance) would decrease. However, as is clear from Table 3, compared with the case of using kit a of Comparative Example 1, in which the concentration of bovine serum albumin in the second reagent containing alkaline phosphatase-labeled aldosterone is 6 g / L, even when using kits C and E of Example 1, in which the concentration of bovine serum albumin in the second reagent is 20 g / L or more, there was no significant change in the amount of luminescence during the measurement of each standard. Therefore, it has become clear that by allowing the labeled steroid hormone and 20 g / L or more of bovine serum albumin to coexist in an aqueous medium in the second reagent, a kit for measuring steroid hormones in a sample, which comprises a first reagent containing an anti-steroid hormone antibody and the second reagent containing a labeled steroid hormone, can be stabilized without reducing the amount of luminescence (signal derived from the labeled substance) during measurement.
[0109] The configurations and combinations thereof in each embodiment are merely examples, and additions, omissions, substitutions, and other modifications of the configurations are possible without departing from the spirit of the present invention. Furthermore, the present invention is not limited to each embodiment, but is limited only by the scope of the claims. [Industrial Applicability]
[0110] The present invention provides a method for stabilizing a kit for measuring steroid hormones in a sample by a competitive method; a kit for measuring steroid hormones in a sample by a competitive method which has excellent stability during long-term storage; a method for stabilizing a labeled steroid hormone; and a labeled steroid hormone-containing reagent which has excellent stability during long-term storage.
Claims
1. A method for stabilizing a kit for measuring a steroid hormone in a sample by a competitive method, the kit comprising a first reagent containing an anti-steroid hormone antibody and a second reagent containing a labeled steroid hormone, the method comprising: A method for stabilizing said labeled steroid hormone, comprising the step of causing said second reagent to coexist with 10 g / L or more of bovine serum albumin in an aqueous medium having a pH of 7 to 8.
2. 2. The method according to claim 1, wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
3. The stabilization method according to claim 1 or 2, wherein the labeled steroid hormone is an enzyme-labeled steroid hormone.
4. 4. The method for stabilization according to claim 3, wherein the enzyme is at least one enzyme selected from the group consisting of alkaline phosphatase and peroxidase.
5. the steroid hormone is aldosterone, the anti-steroid hormone antibody is an anti-aldosterone antibody, The method for stabilization according to any one of claims 1 to 4, wherein the labeled steroid hormone is labeled aldosterone.
6. A method for stabilizing a kit for measuring a steroid hormone in a sample by a competitive method, comprising: a first reagent containing an anti-steroid hormone antibody; and a second reagent which is a solution containing a labeled steroid hormone, the method comprising: The second reagent is characterized in that the labeled steroid hormone and bovine serum albumin of 10 g / L or more are allowed to coexist in an aqueous medium; the steroid hormone is a mineralocorticoid such as aldosterone or fludrocortisone acetate, or a sex hormone such as testosterone, dehydroepiandrosterone, estradiol, estriol, estrone, or progesterone; A stabilization method, wherein the anti-steroid hormone antibody is an antibody against the steroid hormone, and the labeled steroid hormone is a steroid hormone that has been labeled.
7. The steroid hormone is aldosterone, the anti-steroid hormone antibody is an anti-aldosterone antibody, The method for stabilization according to claim 6, wherein the labeled steroid hormone is labeled aldosterone.
8. The stabilization method described in claim 6 or 7, wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
9. a first reagent comprising an anti-steroid hormone antibody; a second reagent comprising an aqueous medium having a pH of 7 to 8, a labeled steroid hormone, and bovine serum albumin at 10 g / L or more; A kit for measuring a steroid hormone in a sample by a competitive method, comprising:
10. The kit according to claim 9, wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
11. 11. The kit according to claim 9 or 10, wherein the labeled steroid hormone is a steroid hormone labeled with at least one enzyme selected from the group consisting of alkaline phosphatase and peroxidase.
12. the anti-steroid hormone antibody is anti-aldosterone; the anti-steroid hormone antibody is an anti-aldosterone antibody, The kit according to any one of claims 9 to 11, wherein the labeled steroid hormone is labeled aldosterone.
13. A first reagent comprising an anti-steroid hormone antibody; a second reagent comprising an aqueous medium, a labeled steroid hormone, and bovine serum albumin at 10 g / L or more; A kit for measuring a steroid hormone in a sample by a competitive method, comprising: the steroid hormone is a mineralocorticoid such as aldosterone or fludrocortisone acetate, or a sex hormone such as testosterone, dehydroepiandrosterone, estradiol, estriol, estrone, or progesterone; A kit, wherein the anti-steroid hormone antibody is an antibody against the steroid hormone, and the labeled steroid hormone is a steroid hormone that has been labeled.
14. The steroid hormone is aldosterone, the anti-steroid hormone antibody is an anti-aldosterone antibody, The kit of claim 13, wherein the labeled steroid hormone is labeled aldosterone.
15. The kit described in claim 13 or 14, wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
16. A method for stabilizing a labeled steroid hormone, which comprises allowing the labeled steroid hormone to coexist with 10 g / L or more of bovine serum albumin in an aqueous medium having a pH of 7-8.
17. The method for stabilizing an albumin composition according to claim 16, wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
18. The stabilization method according to claim 16 or 17, wherein the labeled steroid hormone is a steroid hormone labeled with at least one enzyme selected from the group consisting of alkaline phosphatase and peroxidase.
19. the steroid hormone is aldosterone, The method for stabilization according to any one of claims 16 to 18, wherein the labeled steroid hormone is labeled aldosterone.
20. A method for stabilizing a labeled steroid hormone in a solution, comprising allowing the labeled steroid hormone to coexist with 10 g / L or more of bovine serum albumin in an aqueous medium, A stabilization method, wherein the labeled steroid hormone is labeled aldosterone, labeled fludrocortisone acetate, labeled testosterone, labeled dehydroepiandrosterone, labeled estradiol, labeled estriol, labeled estrone, or labeled progesterone.
21. The stabilization method described in claim 20, wherein the labeled steroid hormone is labeled aldosterone.
22. The stabilization method described in claim 20 or 21, wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
23. a method for measuring a steroid hormone in a sample by a competitive method, which comprises reacting a steroid hormone in the sample with an anti-steroid hormone antibody and a labeled steroid hormone to form an immune complex between the anti-steroid hormone antibody and the labeled steroid hormone, and measuring the label in the immune complex thus formed; A labeled steroid hormone-containing reagent for use in A labeled steroid hormone-containing reagent, characterized in that a labeled steroid hormone and 10 g / L or more of bovine serum albumin coexist in an aqueous medium having a pH of 7-8.
24. The reagent according to claim 23, wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
25. 25. The reagent according to claim 23 or 24, wherein the labeled steroid hormone is a steroid hormone labeled with at least one enzyme selected from the group consisting of alkaline phosphatase and peroxidase.
26. the steroid hormone is aldosterone, the anti-steroid hormone antibody is an anti-aldosterone antibody, The reagent according to any one of claims 23 to 25, wherein the labeled steroid hormone is labeled aldosterone.
27. A method for measuring a steroid hormone in a sample by a competitive method, comprising reacting a steroid hormone in the sample with an anti-steroid hormone antibody and a labeled steroid hormone to form an immune complex between the anti-steroid hormone antibody and the labeled steroid hormone, and measuring the label in the immune complex thus formed. A labeled steroid hormone-containing reagent for use in The method is characterized in that a labeled steroid hormone and bovine serum albumin of 10 g / L or more are present together in an aqueous medium, the steroid hormone is a mineralocorticoid such as aldosterone or fludrocortisone acetate, or a sex hormone such as testosterone, dehydroepiandrosterone, estradiol, estriol, estrone, or progesterone; The reagent, wherein the anti-steroid hormone antibody is an antibody against the steroid hormone, and the labeled steroid hormone is a steroid hormone that has been labeled.
28. The method of claim 1, wherein the steroid hormone is aldosterone. the anti-steroid hormone antibody is an anti-aldosterone antibody, 28. The reagent of claim 27, wherein the labeled steroid hormone is labeled aldosterone.
29. The reagent described in claim 27 or 28, wherein the concentration of the bovine serum albumin is 20 to 30 g / L.
Citation Information
Patent Citations
Immunoassay of aldosterone and kit for said immunoassay
JP1990057976A
Fluorescence labelled substance
JP1992027867A
Small molecule measurement
JP1995270412A
Reduced-type cortisol conjugate
JP2000143691A
Method of measuring steroid hormones in sample
JP2017142241A
